Does TECLISTAMAB-CQYV Cause Thrombosis? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Thrombosis have been filed in association with TECLISTAMAB-CQYV. This represents 0.3% of all adverse event reports for TECLISTAMAB-CQYV.
5
Reports of Thrombosis with TECLISTAMAB-CQYV
0.3%
of all TECLISTAMAB-CQYV reports
0
Deaths
2
Hospitalizations
How Dangerous Is Thrombosis From TECLISTAMAB-CQYV?
Of the 5 reports, 2 (40.0%) required hospitalization.
Is Thrombosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TECLISTAMAB-CQYV. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does TECLISTAMAB-CQYV Cause?
Cytokine release syndrome (406)
Immune effector cell-associated neurotoxicity syndrome (153)
Off label use (122)
Death (116)
Plasma cell myeloma (96)
Infection (83)
Neutropenia (74)
Fatigue (72)
Pyrexia (67)
Covid-19 (64)
What Other Drugs Cause Thrombosis?
LENALIDOMIDE (6,433)
APIXABAN (5,298)
RIVAROXABAN (3,220)
ADALIMUMAB (2,334)
POMALIDOMIDE (1,158)
TOFACITINIB (1,143)
RITUXIMAB (1,083)
ETANERCEPT (1,051)
METHOTREXATE (981)
PREDNISONE (963)
Which TECLISTAMAB-CQYV Alternatives Have Lower Thrombosis Risk?
TECLISTAMAB-CQYV vs TEDIZOLID
TECLISTAMAB-CQYV vs TEDUGLUTIDE
TECLISTAMAB-CQYV vs TEDUGLUTIDE\WATER
TECLISTAMAB-CQYV vs TEGAFUR
TECLISTAMAB-CQYV vs TEGAFUR\URACIL